Sarcopenia and frailty in chronic respiratory disease: Lessons from gerontology

Chronic Respiratory Disease

Volumn 14, Issue 1, 2017, Pages 85-99

  Bone, Anna E ^a   Hepgul, Nilay ^a   Kon, Samantha ^b,c   Maddocks, Matthew ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^c Hillingdon Hospital NHS Trust   (United Kingdom)

Author keywords

COPD; exercise; frail; rehabilitation; respiratory disease; sarcopenia

Indexed keywords

ADL DISABILITY; CHRONIC RESPIRATORY TRACT DISEASE; COGNITION; DISEASE ASSOCIATION; DRUG USE; EXHAUSTION; FALLING; FATIGUE; FRAILTY; HUMAN; INDEPENDENCE; MOOD; MORTALITY; MUSCLE DISEASE; MUSCLE FUNCTION; MUSCLE MASS; MUSCLE STRENGTH; MUSCLE WEAKNESS; PHYSICAL ACTIVITY; PHYSICAL DISABILITY; PHYSICAL MOBILITY; PHYSICAL PERFORMANCE; PREVALENCE; PROGNOSIS; QUALITY OF LIFE; REVIEW; SARCOPENIA; SOCIAL SUPPORT; WEIGHT REDUCTION; AGED; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPLICATION; FRAIL ELDERLY; PATHOPHYSIOLOGY; RESPIRATORY TRACT DISEASE; SKELETAL MUSCLE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CHRONIC DISEASE; FRAIL ELDERLY; HUMANS; MUSCLE WEAKNESS; MUSCLE, SKELETAL; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY TRACT DISEASES; SARCOPENIA;

EID: 85014431017     PISSN: 14799723     EISSN: 14799731     Source Type: Journal    
DOI: 10.1177/1479972316679664     Document Type: Review

References (78)

1. Maltais F, Decramer M, Casaburi R, et al. An official American thoracic society/European respiratory society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2014; 189 (9): e15-e62.
2. Donaldson AV, Maddocks M, Martolini D, et al. Muscle function in COPD: a complex interplay. Int J Chron Obstruct Pulmon Dis 2012; 7: 523.
3. Seymour JM, Spruit MA, Hopkinson NS, et al. The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur Respir J 2010; 36 (1): 81-88.
4. Shrikrishna D, Patel M, Tanner RJ, et al. Quadriceps wasting and physical inactivity in patients with COPD. Eur Respir J 2012; 40 (5): 1115-1122.
5. Natanek SA, Gosker HR, Slot IG, et al. Heterogeneity of quadriceps muscle phenotype in chronic obstructive pulmonary disease (COPD); implications for stratified medicine? Muscle Nerve 2013; 48 (4): 488-497.
6. Swallow EB, Reyes D, Hopkinson NS, et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 2007; 62 (2): 115-120.
7. Marquis K, Debigare R, Lacasse Y, et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166 (6): 809-813.
8. Patel MS, Natanek SA, Stratakos G, et al. Vastus lateralis fiber shift is an independent predictor of mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2014; 190 (3): 350-352.
9. Inouye SK, Studenski S, Tinetti ME, et al. Geriatric syndromes: clinical, research, and policy implications of a core geriatric concept. J Am Geriatr Soc 2007; 55 (5): 780-791.
10. Kalyani RR, Corriere M, Ferrucci L,. Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol 2014; 2 (10): 819-82 9.
11. Cruz-Jentoft AJ, Landi F,. Sarcopenia. Clin Med (Lond) 2014; 14 (2): 183-186.
12. Clegg A, Young J, Iliffe S, et al. Frailty in elderly people. Lancet 2013; 381 (9868): 752-762.
13. Calvani R, Marini F, Cesari M, et al. Biomarkers for physical frailty and sarcopenia: state of the science and future developments. J cachexia Sarcopenia Muscle 2015; 6 (4): 278-286.
14. Vanfleteren LE, Spruit MA, Wouters EF, et al. Management of chronic obstructive pulmonary disease beyond the lungs. The Lancet Respiratory medicine. 2016; 4 (11): 911-924.
15. Morley JE, Abbatecola AM, Argiles JM, et al. Sarcopenia with limited mobility: an international consensus. J Am Med Directors Assoc 2011; 12 (6): 403-409.
16. Mittal N, Raj R, Islam EA, et al. The frequency of frailty in ambulatory patients with chronic lung diseases. J Prim Care Commun Health 2016; 7 (1): 10-15.
17. Lahousse L, Ziere G, Verlinden VJ, et al. Risk of frailty in elderly with COPD: a population-based study. J Gerontol A Biol Sci Med Sci 2015; 71 (5): 689-695.
18. Kon SS, Jones SE, Schofield SJ, et al. Gait speed and readmission following hospitalisation for acute exacerbations of COPD: a prospective study. Thorax 2015; 70 (12): 1131-1137.
19. Singer JP, Diamond JM, Gries CJ, et al. Frailty phenotypes, disability, and outcomes in adult candidates for lung transplantation. Am J Respir Crit Care Med 2015; 192 (11): 1325-1334.
20. Maddocks M, Kon SS, Canavan JL, et al. Physical frailty and pulmonary rehabilitation in COPD: a prospective cohort study. Thorax 2016; 71 (11): 988-995.
21. Park SK, Richardson CR, Holleman RG, et al. Frailty in people with COPD, using the national health and nutrition evaluation survey dataset (2003-2006). Heart Lung 2013; 42 (3): 163-170.
22. Schols AM, Ferreira IM, Franssen FM, et al. Nutritional assessment and therapy in COPD: a European respiratory society statement. Eur Respir J 2014; 44 (6): 1504-1520.
23. von Haehling S, Morley JE, Anker SD,. An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J cachexia Sarcopenia Muscle 2010; 1 (2): 129-133.
24. Delmonico MJ, Harris TB, Lee JS, et al. Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J Am Geriatr Soc 2007; 55 (5): 769-774.
25. Goodpaster BH, Park SW, Harris TB, et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci 2006; 61 (10): 1059-1064.
26. Rosenberg IH,. Sarcopenia: origins and clinical relevance. J Nutr 1997; 127 (5 Suppl): 990S-991S.
27. Argiles JM, Muscaritoli M,. The three faces of sarcopenia. J Am Med Dir Assoc 2016; 17 (6): 471-472.
28. Timiras PS,. Disuse and aging: same problem, different outcomes. J Gravit Physiol 1994; 1 (1): P5-P7.
29. Lee JS, Auyeung TW, Kwok T, et al. Associated factors and health impact of sarcopenia in older Chinese men and women: a cross-sectional study. Gerontology 2007; 53 (6): 404-410.
30. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010; 39 (4): 412-423.
31. Spruit MA, Watkins ML, Edwards LD, et al. Determinants of poor 6-min walking distance in patients with COPD: the ECLIPSE cohort. Respir Med 2010; 104 (6): 849-857.
32. Collard RM, Boter H, Schoevers RA, et al. Prevalence of frailty in community-dwelling older persons: a systematic review. J Am Geriatr Soc 2012; 60 (8): 1487-1492.
33. Song X, Mitnitski A, Rockwood K,. Prevalence and 10-year outcomes of frailty in older adults in relation to deficit accumulation. J Am Geriatr Soc 2010; 58 (4): 681-687.
34. Eeles EM, White SV, O'Mahony SM, et al. The impact of frailty and delirium on mortality in older inpatients. Age Ageing 2012; 41 (3): 412-416.
35. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56 (3): M146-M156.
36. Theou O, Brothers TD, Pena FG, et al. Identifying common characteristics of frailty across seven scales. J Am Geriatr Soc 2014; 62 (5): 901-906.
37. Mitnitski AB, Song X, Rockwood K,. The estimation of relative fitness and frailty in community-dwelling older adults using self-report data. J Gerontol A Biol Sci Med Sci 2004; 59 (6): M627-M632.
38. Rockwood K, Song X, MacKnight C, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ 2005; 173 (5): 489-495.
39. Rockwood K, Mitnitski A,. Limits to deficit accumulation in elderly people. Mech Ageing Dev 2006; 127 (5): 494-496.
40. Muscaritoli M, Anker SD, Argiles J, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". Clin Nutr 2010; 29 (2): 154-159.
41. Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 2011; 12 (4): 249-256.
42. Lee ES, Park HM,. Prevalence of Sarcopenia in Healthy Korean Elderly Women. J Bone Metab 2015; 22 (4): 191-195.
43. Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 2014; 15 (2): 95-101.
44. Dam TT, Peters KW, Fragala M, et al. An evidence-based comparison of operational criteria for the presence of sarcopenia. J Gerontol A Biol Sci Med Sci 2014; 69 (5): 584-590.
45. Woo J, Leung J, Morley JE,. Validating the SARC-F: a suitable community screening tool for sarcopenia? J Am Med Dir Assoc 2014; 15 (9): 630-634.
46. Morley JE, Malmstrom TK, Miller DK,. A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans. J Nutr Health Aging 2012; 16 (7): 601-608.
47. Mitnitski AB, Graham JE, Mogilner AJ, et al. Frailty, fitness and late-life mortality in relation to chronological and biological age. BMC Geriatr 2002; 2: 1.
48. Clegg A, Bates C, Young J, et al. Development and validation of an electronic frailty index using routine primary care electronic health record data. Age Ageing 2016; 45 (3): 353-360.
49. Gobbens RJ, van Assen MA, Luijkx KG, et al. The Tilburg Frailty Indicator: psychometric properties. J Am Med Dir Assoc 2010; 11 (5): 344-355.
50. Rolfson DB, Majumdar SR, Tsuyuki RT, et al. Validity and reliability of the Edmonton Frail Scale. Age Ageing 2006; 35 (5): 526-529.
51. Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998; 147 (8): 755-763.
52. Steiner M, Barton R, Singh S, et al. Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD. Eur Respir J 2002; 19 (4): 626-631.
53. Cawthon PM, Peters KW, Shardell MD, et al. Cutpoints for low appendicular lean mass that identify older adults with clinically significant weakness. J Gerontol A Biol Sci Med Sci 2014; 69 (5): 567-575.
54. Maddocks M, Jones SE, Kon SS, et al. Sarcopenia definitions: where to draw the line? Response to Scarlata et al. Thorax 2015; 70 (7): 694.
55. Maddocks M, Kon SS, Jones SE, et al. Bioelectrical impedance phase angle relates to function, disease severity and prognosis in stable chronic obstructive pulmonary disease. Clin Nutr 2015; 34 (6): 1245-1250.
56. Kon SS, Canavan JL, Nolan CM, et al. The 4-metre gait speed in COPD: responsiveness and minimal clinically important difference. Eur Respir J 2014; 43 (5): 1298-1305.
57. Kon SS, Patel MS, Canavan JL, et al. Reliability and validity of 4-metre gait speed in COPD. Eur Respir J 2013; 42 (2): 333-340.
58. Norman K, Stobaus N, Gonzalez MC, et al. Hand grip strength: outcome predictor and marker of nutritional status. Clin Nutr 2011; 30 (2): 135-142.
59. Beaudart C, Reginster JY, Slomian J, et al. Estimation of sarcopenia prevalence using various assessment tools. Exp Gerontol 2015; 61: 31-37.
60. Lee WJ, Liu LK, Peng LN, et al. Comparisons of sarcopenia defined by IWGS and EWGSOP criteria among older people: results from the I-Lan longitudinal aging study. J Am Med Dir Assoc 2013; 14 (7): 528. e1-7.
61. Rockwood K, Mitnitski A,. Frailty defined by deficit accumulation and geriatric medicine defined by frailty. Clin Geriatr Med 2011; 27 (1): 17-26.
62. Sternberg SA, Wershof Schwartz A, Karunananthan S, et al. The identification of frailty: a systematic literature review. J Am Geriatr Soc 2011; 59 (11): 2129-2138.
63. Buta BJ, Walston JD, Godino JG, et al. Frailty assessment instruments: systematic characterization of the uses and contexts of highly-cited instruments. Ageing Res Rev 2016; 26: 53-61.
64. de Vries NM, Staal JB, van Ravensberg CD, et al. Outcome instruments to measure frailty: a systematic review. Ageing Res Rev 2011; 10 (1): 104-114.
65. Jones SE, Maddocks M, Kon SS, et al. Sarcopenia in COPD: prevalence, clinical correlates and response to pulmonary rehabilitation. Thorax 2015; 70 (3): 213-218.
66. Akgün KM, Tate JP, Oursler KK, et al. Association of chronic obstructive pulmonary disease (COPD) with frailty measurements in HIV-infected and uninfected Veterans. AIDS 2016; 30 (14): 2185-2193.
67. Valenza MC, Torres-Sanchez I, Cabrera-Martos I, et al. Physical activity as a predictor of absence of frailty in subjects with stable COPD and COPD exacerbation. Respir Care 2016; 61 (2): 212-219.
68. Galizia G, Cacciatore F, Testa G, et al. Role of clinical frailty on long-term mortality of elderly subjects with and without chronic obstructive pulmonary disease. Aging Clin Exp Res 2011; 23 (2): 118-125.
69. Vaz Fragoso CA, Enright PL, McAvay G, et al. Frailty and respiratory impairment in older persons. Am J Med 2012; 125 (1): 79-86.
70. Mittal N Raj R, Islam E pulmonary rehabilitation improves frailty and gait speed in some ambulatory patients with chronic lung diseases. SWRCCC 2015; 3 (12): 2-10.
71. Donaldson GC, Law M, Kowlessar B, et al. Impact of prolonged exacerbation recovery in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2015; 192 (8): 943-950.
72. Greening NJ, Harvey-Dunstan TC, Chaplin EJ, et al. Bedside assessment of quadriceps muscle using ultrasound following admission for acute exacerbations of chronic respiratory disease. Am J Respir Crit Care Med 2015; 192 (7): 810-816.
73. Theou O, Stathokostas L, Roland KP, et al. The effectiveness of exercise interventions for the management of frailty: a systematic review. J Aging Res 2011; 2011: 569194.
74. Vogiatzis I, Rochester CL, Spruit MA, et al. Increasing implementation and delivery of pulmonary rehabilitation: key messages from the new ATS/ERS policy statement. Eur Respir J 2016; 47 (5): 1336-1341.
75. Maddocks M, Nolan CM, Man WD, et al. Neuromuscular electrical stimulation to improve exercise capacity in patients with severe COPD: a randomised double-blind, placebo-controlled trial. Lancet Respir Med 2016; 4 (1): 27-36.
76. Morley JE, Vellas B, van Kan GA, et al. Frailty consensus: a call to action. J Am Med Dir Assoc 2013; 14 (6): 392-397.
77. Turner G, Clegg A,. Best practice guidelines for the management of frailty: a British Geriatrics Society, Age UK and Royal College of General Practitioners report. Age Ageing 2014; 43 (6): 744-747.
78. Steiner MC, Roubenoff R, Tal-Singer R, et al. Prospects for the development of effective pharmacotherapy targeted at the skeletal muscles in chronic obstructive pulmonary disease: a translational review. Thorax 2012; 67 (12): 1102-1109.